The economic impact of inherited retinal diseases: asystematic literature review

Simple item page
dc.contributor.authorWillmington, Claireen
dc.contributor.authorMurphy, Aileenen
dc.contributor.authorKirby, Annen
dc.contributor.funderEuropean Commissionen
dc.date.accessioned2025-02-25T12:48:18Z
dc.date.available2025-02-25T12:48:18Z
dc.date.issued2024en
dc.description.abstractAffecting over 2 million people worldwide, inherited retinal disease (IRD) is considered one of the leading causes of blindness among the working-age population. The recent market entry of Luxturna® to treat Leber Congenital Amaurosis (LCA) presents gene therapy as a promising option for IRD patients in the future. Furthermore, given the rarity of IRD and the high price of innovative medicines, it is essential to consider the current costs associated with IRD.en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationWillmington, C., Murphy, A. and Kirby, A. (2024) 'The economic impact of inherited retinal diseases: a systematic literature review', RIWC24: Targeting the Cure, Dublin, Ireland, 7 June.en
dc.identifier.urihttps://hdl.handle.net/10468/17115
dc.language.isoenen
dc.rights2024, the Authors.en
dc.subjectEconomic impacten
dc.subjectInherited retinal diseasesen
dc.titleThe economic impact of inherited retinal diseases: asystematic literature reviewen
dc.typeConference itemen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Poster_RIWC24_0624_Claire Willmington.pdf
Size:
752.22 KB
Format:
Adobe Portable Document Format
Description:
Published Version
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Economics - Conference Items